Cost-effectiveness of prasugrel versus clopidogrel in patients with acute coronary syndromes and planned percutaneous coronary intervention: results from the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with Prasugrel-Thrombolysis in Myocardial Infarction TRITON-TIMI 38.

Authors :: Mahoney EM
Wang K
Arnold SV
Proskorovsky I
Wiviott S
Antman E
Braunwald E
Cohen DJ
Source :: Circulation; 1/5/2010, Vol. 121 Issue 1, p71-79, 9p
Publication Year :: 2010

Full Text Access

Tools